[HTML][HTML] In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia

NS Ku, SH Lee, Y Lim, H Choi, JY Ahn, SJ Jeong… - Scientific reports, 2019 - nature.com
Unfortunately, the options for treating multidrug-resistant (MDR) Acinetobacter baumannii (A.
baumannii) infections are extremely limited. Recently, fosfomycin and minocycline were …

In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia.

NS Ku, SH Lee, YS Lim, H Choi, JY Ahn… - Scientific …, 2019 - europepmc.org
Unfortunately, the options for treating multidrug-resistant (MDR) Acinetobacter baumannii (A.
baumannii) infections are extremely limited. Recently, fosfomycin and minocycline were …

In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia

NS Ku, SH Lee, YS Lim, H Choi, JY Ahn… - Scientific …, 2019 - pubmed.ncbi.nlm.nih.gov
Unfortunately, the options for treating multidrug-resistant (MDR) Acinetobacter baumannii (A.
baumannii) infections are extremely limited. Recently, fosfomycin and minocycline were …

In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia

NS Ku, SH Lee, Y Lim, H Choi, JY Ahn… - Scientific …, 2019 - ui.adsabs.harvard.edu
Unfortunately, the options for treating multidrug-resistant (MDR) Acinetobacter baumannii (A.
baumannii) infections are extremely limited. Recently, fosfomycin and minocycline were …

In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia

NS Ku, SH Lee, Y Lim, H Choi, JY Ahn, SJ Jeong… - 2019 - ir.ymlib.yonsei.ac.kr
Unfortunately, the options for treating multidrug-resistant (MDR) Acinetobacter baumannii (A.
baumannii) infections are extremely limited. Recently, fosfomycin and minocycline were …

[PDF][PDF] In vivoefficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumanniipneumonia

NS Ku, SH Lee, Y Lim, H Choi, JY Ahn, SJ Jeong… - core.ac.uk
Results Antibiotic susceptibility tests. Table 1 shows the minimum inhibitory concentrations
(MICs) of piperacillin/tazobactam, ceftazidime, imipenem, amikacin, ciprofloxacin …

In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia

NS Ku, SH Lee, YS Lim, H Choi, JY Ahn, SJ Jeong… - repository.ajou.ac.kr
Unfortunately, the options for treating multidrug-resistant (MDR) Acinetobacter baumannii (A.
baumannii) infections are extremely limited. Recently, fosfomycin and minocycline were …

[HTML][HTML] In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia

NS Ku, SH Lee, Y Lim, H Choi, JY Ahn, SJ Jeong… - Scientific …, 2019 - ncbi.nlm.nih.gov
Unfortunately, the options for treating multidrug-resistant (MDR) Acinetobacter baumannii (A.
baumannii) infections are extremely limited. Recently, fosfomycin and minocycline were …

In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia

NS Ku, SH Lee, Y soun Lim, H Choi… - Scientific …, 2019 - yonsei.elsevierpure.com
Unfortunately, the options for treating multidrug-resistant (MDR) Acinetobacter baumannii (A.
baumannii) infections are extremely limited. Recently, fosfomycin and minocycline were …

In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia.

NS Ku, SH Lee, Y Lim, H Choi, JY Ahn… - Scientific …, 2019 - search.ebscohost.com
Unfortunately, the options for treating multidrug-resistant (MDR) Acinetobacter baumannii (A.
baumannii) infections are extremely limited. Recently, fosfomycin and minocycline were …